Patent Yard Sign in
Expired Canadian patentCanada

Rapid differentiation of bacteria using cyclic polypeptide antibiotics

CA 1293911 C · Owner: Eastman Kodak Company · Inventors: Cichanowicz, Peggy W.; Belly, Robert T.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Abstract of the Disclosure Rapid differentiation between viable grampositive and gram-negative bacteria is accomplished with certain polypeptide antibiotics which are used in combination with a compound which is normally reducible by the bacteria, The antibiotics selectively inhibit the reduction of the reducible compound by gram-positive bacteria but do not substantially affect the reducing capacity of the gramnegative bacteria. The particular antibiotics useful are cyclic polypeptides which affect the function of the cytoplasmic membrane of bacteria. A particular polypeptide antibiotic, polymixin B, will distinguish Proteus bacteria from other gram-negative genera.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted January 7, 1992. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended January 7, 2009.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 5, 1986
GrantedJanuary 7, 1992
Term endedJanuary 7, 2009
Patent numberCA 1293911 C
Classification (IPC)C12Q1/04 +1 more

Timeline

Timeline From CIPO dates

19871990199319961999200220052008Application filedDec 5, 1986Patent grantedJan 7, 1992Term endedJan 7, 2009

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.